• SENSEX 76,738.17
    585.31 (+0.77%)
  • BANKNIFTY 57,380.60
    208.60 (+0.36%)
  • Gland Pharma
    2,826.60 1,575.00(%)
  • Tata Technolog.
    830.10 890.15(%)
  • IFCI
    103.95 101.60(%)
  • HFCL
    231.40 257.00(%)
  • Lumino Inds
    122.00 119.00(%)
  • Jindal Worldwide
    57.06 47.55(%)
  • Netweb Technol.
    5,424.00 5,810.00(%)
  • Angel One
    308.20 360.20(%)
  • HBL Engineering
    723.85 1,121.95(%)
  • Multi Comm. Exc.
    3,257.00 3,479.80(%)
  • Adani Total Gas
    620.85 859.70(%)
  • Lenskart Solut.
    694.75 680.95(%)
  • Oberoi Realty
    1,932.25 1,985.00(%)
  • RBL Bank
    413.50 410.45(%)
  • Tejas Networks
    613.50 644.75(%)
  • Polycab India
    8,308.55 6,660.50(%)
  • Antelopus Selan
    986.05 357.00(%)
  • Nuvoco Vistas
    353.50 477.35(%)
  • One 97
    1,691.50 1,732.00(%)
  • Reliance Industries
    1,332.30 1,611.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Krebs Biochemicals & Industries Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 3697.0
  • ISIN : INE268B01013
54.50 0 (-0.75%)
  • As on 04 Sep 2026 (EOD)

  • Today’s Low

    53.65

  • Today’s High

    56.40

  • Open

    53.65

  • Perv Close

    54.91

  • 52W Low

    38.33

  • 52W High

    82.49

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    117.51

  • Div & Yield %

    0.00

  • Book Value(₹)

    -75.49

  • Debt-Equity Ratio

    -0.75

  • AGM Date

    03-Sep-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    117.51

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    21.56

  • BV (₹)

    -75.50

  • Sales( ₹ in Cr.)

    23.73

  • NP (in Cr.)

    -16.93

  • NP Var(%)

    37.0

  • Div%

    0.0

  • CPS (₹)

    -4.90

  • EPS (₹)

    -7.90

  • Traded Value (₹ in Lakhs)

    112.37

  • 52 Week High

    82.49

  • 52 Week Low

    38.33

  • Price BSE

    52.0

  • Price NSE

    55.00

  • Market Capital( in Cr.)

    112.37

  • P/C Ratio

    -10.70

  • P/E Ratio

    -6.60

  • Price Vs.BV

    -7.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 43.31 50.42 52.13 59.70 53.70 33.41
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 43.31 50.42 52.13 59.70 53.70 33.41
Other Income 0.71 0.45 0.62 1.16 0.62 0.37
Stock Adjustments -3.03 -1.07 -5.87 5.54 -0.32 3.32
Total Income 40.99 49.80 46.88 66.40 54.00 37.10
EXPENDITURE :            
Raw Materials 2.53 5.52 19.81 46.18 25.62 19.18
Power and Fuel Cost 18.52 22.01 14.80 22.23 15.91 10.28
Employee Cost 16.30 16.17 15.54 14.96 15.30 14.56
Other Manufacturing Expenses 12.59 9.75 7.17 9.64 10.48 6.95
Selling and Administration Expenses 5.24 4.50 4.57 6.11 3.39 4.01
Miscellaneous Expenses 0.13 0.11 0.17 0.11 0.24 0.31
Employee Benefit Expenses 16.30 16.17 15.54 14.96 15.30 14.56
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 55.32 58.08 62.05 99.24 70.95 55.29
Operating Profit -14.32 -8.27 -15.16 -32.84 -16.95 -18.19
Interest 5.91 4.69 2.97 5.39 6.28 6.00
Gross Profit -20.23 -12.96 -18.13 -38.23 -23.23 -24.19
Depreciation 6.69 6.77 6.56 6.30 5.12 4.68
Profit Before Tax -26.92 -19.73 -24.69 -44.53 -28.35 -28.87
Current Tax 0.02 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit -26.94 -19.73 -24.69 -44.53 -28.36 -28.87
Extraordinary Items 0.12 0.00 0.00 0.00 0.00 0.01
Adjusted Net Profit -27.06 -19.73 -24.69 -44.53 -28.36 -28.88
Adjustment below Net Profit -0.08 -0.03 0.32 -0.35 0.17 6.38
P & L Balance brought forward -270.24 -250.49 -226.12 -181.24 -153.06 -111.86
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -297.26 -270.24 -250.49 -226.12 -181.24 -134.35
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -12.49 -9.15 -11.45 -20.65 -14.45 -16.04
Earnings Per Share(Adj)-Unit Curr -12.49 -9.15 -11.45 -20.65 -14.45 -16.04
Book Value -67.83 -55.29 -46.13 -34.83 -23.91 -13.89
Book Value(Adj)-Unit Curr -67.83 -55.29 -46.13 -34.83 -23.91 -13.89

Shareholding Pattern

  • Promoter Group

    72.74%

  • Public Share Holding

    27.26%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 10,705,195 49.65 10,705,195 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,978,939 23.09 4,958,539 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 15,684,134 72.74 15,663,734 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 1,822 0.01 522 4
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 105,000 0.49 105,000 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 106,822 0.50 105,522 5
2] Non Institution
Bodies Corporate 1,092,611 5.07 1,089,010 72
Clearing Members 0 0.00 0 0
Directors of their Relatives 7,837 0.04 7,837 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 279,778 1.30 279,778 102
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 149,484 0.69 149,484 193
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,971,605 9.14 1,761,605 25
Individuals holding nominal share capital up to Rs. 1 lakh 2,268,313 10.52 2,151,783 8,114
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2 0.00 2 2
Sub Total 5,769,630 26.76 5,439,499 8,510
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 21,560,586 100.00 21,208,755 8,521

Company Background

Krebs Biochemicals & Industries LtdPharmaceuticals - Indian - Bulk Drugs

  • Krebs Biochemicals & Industries Ltd
  • BSE Code : 3697.0
  • ISIN : INE268B01013

  • Incorporation Year

    1991

  • Registered Office

    Kothapalli(V) Kasimkota(M)
    Anakapalli, Vishakapatnam,
    Andhra Pradesh-531031

  • Telephone

    91-040-6680 8040

  • FAX

  • Chairman

    R T Ravi

  • Managing Director

    Manish Kumar Jain

  • Company Secretary

    Rakesh R Kalbate

  • Auditor

    Bhavani & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Krebs Biochemicals & Industries Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Krebs Biochem 52.12 44.02 43.31 -7.97 0.00
Abbott India 25,878.50 7,217.19 6,929.05 34.06 43.78
Astrazeneca Phar 6,946.95 2,304.07 2,275.58 102.39 27.86
Glaxosmi. Pharma 2,935.35 3,932.76 3,790.20 46.89 58.17
Novartis India 1,614.95 398.23 356.27 40.78 16.64
Cipla 1,389.00 20,102.60 18,979.95 36.50 13.88
Bliss GVS Pharma 636.90 773.53 729.81 59.14 12.51
Amrutanjan Healt 507.20 520.13 502.55 27.17 24.16
Fermenta Biotec. 502.80 474.15 450.25 23.47 18.77
Guj. Themis Bio. 425.00 152.47 150.80 113.64 27.21
Ambalal Sarabhai 43.88 19.52 3.94 81.26 6.77